The University of Chicago Header Logo

Connection

John Fung to Bone Marrow Transplantation

Back to Details
This is a "connection" page, showing publications John Fung has written about Bone Marrow Transplantation.
John Fung
Connection Strength
2.360
Bone Marrow Transplantation
  1. Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):1352.
    View in: PubMed
    Score: 0.174
  2. Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc. 1999 Feb-Mar; 31(1-2):700-1.
    View in: PubMed
    Score: 0.152
  3. Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc. 1995 Feb; 27(1):509-10.
    View in: PubMed
    Score: 0.115
  4. Bone marrow augmentation in solid organ transplantation--any conclusions? Hepatology. 1995 Jan; 21(1):260-1.
    View in: PubMed
    Score: 0.114
  5. A new xenogeneic radiation chimera (hamster-to-rat). Transplantation. 1994 May 27; 57(10):1528-32.
    View in: PubMed
    Score: 0.110
  6. Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. Bone Marrow Transplant. 1993 Jun; 11(6):502.
    View in: PubMed
    Score: 0.102
  7. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc. 1991 Dec; 23(6):3234-5.
    View in: PubMed
    Score: 0.092
  8. Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. Transplant Proc. 1991 Dec; 23(6):3238-9.
    View in: PubMed
    Score: 0.092
  9. The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras. Transplant Proc. 1990 Dec; 22(6):2536-8.
    View in: PubMed
    Score: 0.086
  10. Overview of FK506 in transplantation. Clin Transpl. 1990; 115-21.
    View in: PubMed
    Score: 0.081
  11. Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation. 2004 Mar 27; 77(6):926-9.
    View in: PubMed
    Score: 0.054
  12. Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. Xenotransplantation. 2001 Aug; 8(3):213-21.
    View in: PubMed
    Score: 0.045
  13. Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1134-5.
    View in: PubMed
    Score: 0.044
  14. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals. Transplantation. 2000 Nov 27; 70(10):1507-15.
    View in: PubMed
    Score: 0.043
  15. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease. Transplant Proc. 2000 Aug; 32(5):1032-3.
    View in: PubMed
    Score: 0.042
  16. Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. Transplant Proc. 2000 Aug; 32(5):1036-7.
    View in: PubMed
    Score: 0.042
  17. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg. 2000 Apr; 119(4 Pt 1):673-81.
    View in: PubMed
    Score: 0.041
  18. Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg. 2000 Feb; 69(2):345-50.
    View in: PubMed
    Score: 0.041
  19. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg. 1999 Sep; 230(3):372-9; discussion 379-81.
    View in: PubMed
    Score: 0.039
  20. Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol. 1999 Aug; 66(2):310-4.
    View in: PubMed
    Score: 0.039
  21. Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc. 1998 Jun; 30(4):1367-8.
    View in: PubMed
    Score: 0.036
  22. Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons. Transplantation. 1997 Dec 15; 64(11):1595-8.
    View in: PubMed
    Score: 0.035
  23. Tolerance and chimerism in liver transplantation. Transplant Proc. 1997 Nov; 29(7):2817-8.
    View in: PubMed
    Score: 0.035
  24. Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. Transplant Proc. 1997 Jun; 29(4):2175-6.
    View in: PubMed
    Score: 0.034
  25. Perioperative donor bone marrow infusion in recipients of organ allografts. Transplant Proc. 1997 Jun; 29(4):2192-3.
    View in: PubMed
    Score: 0.034
  26. Chimerism after organ transplantation. Curr Opin Nephrol Hypertens. 1997 May; 6(3):292-8.
    View in: PubMed
    Score: 0.034
  27. Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1184-5.
    View in: PubMed
    Score: 0.033
  28. Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. Transplant Proc. 1997 Feb-Mar; 29(1-2):700.
    View in: PubMed
    Score: 0.033
  29. An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol. 1997; 417:269-74.
    View in: PubMed
    Score: 0.033
  30. Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc. 1996 Oct; 28(5):2757-8.
    View in: PubMed
    Score: 0.032
  31. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc. 1996 Oct; 28(5):2959-65.
    View in: PubMed
    Score: 0.032
  32. Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin. Transplantation. 1996 Apr 27; 61(8):1228-33.
    View in: PubMed
    Score: 0.031
  33. Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. Transplant Proc. 1996 Apr; 28(2):733-4.
    View in: PubMed
    Score: 0.031
  34. Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. Transplant Proc. 1996 Apr; 28(2):736-7.
    View in: PubMed
    Score: 0.031
  35. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. J Clin Invest. 1996 Jan 01; 97(1):217-25.
    View in: PubMed
    Score: 0.031
  36. The bidirectional paradigm of transplant immunology. Ann N Y Acad Sci. 1995 Dec 29; 770:165-76.
    View in: PubMed
    Score: 0.031
  37. Human islet transplantation: results of the first 37 patients. Transplant Proc. 1995 Dec; 27(6):3162-3.
    View in: PubMed
    Score: 0.030
  38. Explanation for loss of the HLA matching effect. Transplant Proc. 1995 Feb; 27(1):57-60.
    View in: PubMed
    Score: 0.029
  39. The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp. 1995; 24:341-54.
    View in: PubMed
    Score: 0.029
  40. Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
    View in: PubMed
    Score: 0.028
  41. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc. 1993 Dec; 25(6):3337-44.
    View in: PubMed
    Score: 0.026
  42. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3225-7.
    View in: PubMed
    Score: 0.023
  43. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3232-3.
    View in: PubMed
    Score: 0.023
  44. Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation. 1991 Oct; 52(4):590-4.
    View in: PubMed
    Score: 0.023
  45. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery. 1991 Aug; 110(2):357-63; discussion 363-4.
    View in: PubMed
    Score: 0.023
  46. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. Clin Transpl. 1999; 217-21.
    View in: PubMed
    Score: 0.009
  47. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
    View in: PubMed
    Score: 0.009
  48. An attempt to reverse diabetes by delayed islet cell transplantation in humans. Transplant Proc. 1997 Jun; 29(4):2238-9.
    View in: PubMed
    Score: 0.008
  49. Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience. Transplant Proc. 1997 Feb-Mar; 29(1-2):746-7.
    View in: PubMed
    Score: 0.008
  50. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats. Cell Transplant. 1993 Jul-Aug; 2(4):345-53.
    View in: PubMed
    Score: 0.006
  51. [Clinical experience with FK 506]. Presse Med. 1991 Nov 27; 20(40):1967-73.
    View in: PubMed
    Score: 0.006
  52. Use of FK 506 in pediatric patients. Transplant Proc. 1991 Feb; 23(1 Pt 2):924-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.